|
OMIM |
Link |
Information gain |
01 |
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.010112
|
|
|
oslam syndrome
|
[NCBI]
|
0.00296772
|
|
|
IDDM
|
[NCBI]
|
0.000838779
|
|
|
LIP
|
[NCBI]
|
0.000505934
|
|
|
HAM
|
[NCBI]
|
0.000463425
|
|
|
SLE
|
[NCBI]
|
0.00035959
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000333666
|
|
|
EV
|
[NCBI]
|
0.000241803
|
|
|
hodgkin lymphoma
|
[NCBI]
|
0.000167223
|
|
|
XLP1
|
[NCBI]
|
0.000163326
|
|
|
kaposi sarcoma
|
[NCBI]
|
0.000138518
|
|
|
IL2
|
[NCBI]
|
0.0001242
|
|
|
inosine phosphorylase deficiency, immune defect due to
|
[NCBI]
|
0.000116605
|
|
|
MBP
|
[NCBI]
|
0.000111332
|
|
|
ataxic diplegia with defective cellular immunity
|
[NCBI]
|
8.51509e-05
|
|
|
epstein-barr virus, susceptibility to chronic infection by
|
[NCBI]
|
8.51509e-05
|
|
|
CHS
|
[NCBI]
|
7.13452e-05
|
|
|
west nile virus, susceptibility to
|
[NCBI]
|
6.01363e-05
|
|
|
MG
|
[NCBI]
|
5.86334e-05
|
|
|
ragweed sensitivity
|
[NCBI]
|
5.56846e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
5.56846e-05
|
|
|
SRC
|
[NCBI]
|
5.14086e-05
|
|
|
CF
|
[NCBI]
|
5.00519e-05
|
|
|
CHH
|
[NCBI]
|
4.76822e-05
|
|
|
AGS1
|
[NCBI]
|
3.96729e-05
|
|
|
TNF
|
[NCBI]
|
3.91724e-05
|
|
|
CD47
|
[NCBI]
|
3.77254e-05
|
|
|
HS
|
[NCBI]
|
3.77254e-05
|
|
|
ADA
|
[NCBI]
|
3.47281e-05
|
|
|
VWM
|
[NCBI]
|
3.21267e-05
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
2.58785e-05
|
|
|
CD
|
[NCBI]
|
2.56899e-05
|
|
|
HTLVR
|
[NCBI]
|
2.53555e-05
|
|
|
HYAL2
|
[NCBI]
|
2.53555e-05
|
|
|
BL
|
[NCBI]
|
2.49805e-05
|
|
|
CD81
|
[NCBI]
|
2.46866e-05
|
|
|
ITGAL
|
[NCBI]
|
2.46866e-05
|
|
|
OAS1
|
[NCBI]
|
2.35586e-05
|
|
|
CCL3
|
[NCBI]
|
2.2219e-05
|
|
|
TBX21
|
[NCBI]
|
2.11509e-05
|
|
|
XCL1
|
[NCBI]
|
2.05427e-05
|
|
|
FUT2
|
[NCBI]
|
1.99975e-05
|
|
|
AT
|
[NCBI]
|
1.85954e-05
|
|
|
TCRB
|
[NCBI]
|
1.8069e-05
|
|
|
TLR7
|
[NCBI]
|
1.78927e-05
|
|
|
PDGFB
|
[NCBI]
|
1.78927e-05
|
|
|
CD40LG
|
[NCBI]
|
1.75572e-05
|
|
|
CJD
|
[NCBI]
|
1.75196e-05
|
|
|
TNFRSF14
|
[NCBI]
|
1.7242e-05
|
|
|
CTLA4
|
[NCBI]
|
1.60214e-05
|
|
|
aHUS
|
[NCBI]
|
1.58271e-05
|
|
|
CSF2
|
[NCBI]
|
1.55596e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.54538e-05
|
|
|
C4A
|
[NCBI]
|
1.53433e-05
|
|
|
CCL21
|
[NCBI]
|
1.52385e-05
|
|
|
PVR
|
[NCBI]
|
1.46511e-05
|
|
|
NP
|
[NCBI]
|
1.38804e-05
|
|
|
CEACAM1
|
[NCBI]
|
1.37239e-05
|
|
|
JAK3
|
[NCBI]
|
1.33528e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.32277e-05
|
|
|
CD36
|
[NCBI]
|
1.30744e-05
|
|
|
IL10
|
[NCBI]
|
1.27469e-05
|
|
|
BTK
|
[NCBI]
|
1.26839e-05
|
|
|
RP
|
[NCBI]
|
1.192e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
1.18769e-05
|
|
|
PIGR
|
[NCBI]
|
1.08709e-05
|
|
|
AFP
|
[NCBI]
|
1.08557e-05
|
|
|
IL6
|
[NCBI]
|
8.58268e-06
|
|
|
JMML
|
[NCBI]
|
8.30291e-06
|
|
|
ALK
|
[NCBI]
|
7.62936e-06
|
|
|
DCK
|
[NCBI]
|
7.60797e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
7.00334e-06
|
|
|
TNFSF10
|
[NCBI]
|
6.14271e-06
|
|
|
EGF
|
[NCBI]
|
6.0559e-06
|
|
|
MBL2
|
[NCBI]
|
5.53034e-06
|
|
|
TNFSF6
|
[NCBI]
|
5.15775e-06
|
|
|
VEGF
|
[NCBI]
|
4.96219e-06
|
|
|
CPI
|
[NCBI]
|
4.48529e-06
|
|
|
PRL
|
[NCBI]
|
4.27827e-06
|
|
|
HP
|
[NCBI]
|
3.63042e-06
|
|
|
ALB
|
[NCBI]
|
2.96769e-06
|
|
|
EPO
|
[NCBI]
|
2.94586e-06
|
|
|
CFTR
|
[NCBI]
|
2.93911e-06
|
|
|
KLK3
|
[NCBI]
|
1.83363e-06
|
|
|
EGFR
|
[NCBI]
|
1.6394e-06
|
|
|
AHR
|
[NCBI]
|
1.54541e-06
|
|
|
SPP1
|
[NCBI]
|
1.41507e-06
|
|
|
GDNF
|
[NCBI]
|
1.33054e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.26537e-06
|
|
|
WAS
|
[NCBI]
|
1.23116e-06
|
|
|
NGFB
|
[NCBI]
|
6.17455e-07
|
|
|
DHFR
|
[NCBI]
|
5.05502e-07
|
|
|
temporal arteritis
|
[NCBI]
|
1.6253e-07
|
|
|
RA
|
[NCBI]
|
4.37784e-08
|
|